Viage Therapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Viage Therapeutics?

Viage Therapeutics has 5 investors including Kyoto University Innovation Capital And ANRI.

Q: How much funding has Viage Therapeutics raised to date?

Viage Therapeutics has raised obfuscated.

Overview

Viage Therapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Viage Therapeutics

CB Rank

80009

Viage Therapeutics is a biotech company that develops therapeutics that stimulates the central nervous system via the gut-brain axis.

Founded

obfuscation

Private

Seed

San Francisco, California, United States

1-10

viagetx.com

Biotechnology

Clinical Trials

Medical

Neuroscience

Funding Rounds

Seed

OBF

obfuscation

Details

Legal Name

Viage Therapeutics, Inc.

Also Known As

Digestome Therapeutics

Operating Status

Active

Company Type

For Profit

About the Company

Viage Therapeutics, a neuroscience company based on a platform of novel neurotherapeutics, was founded in 2018. The company is based on the ground-breaking research.

Contact Email

info@viagetx.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

DGX-001

An oral drug candidate that targets the gut-brain axis by modulating the vagus nerve through receptor interactions on gut enteroendocrine cells to regulate brain activity.

Pipeline of Novel Neuropeptides and DGX-001-Derived Peptides and Small Molecules

A development pipeline of gut-acting neuropeptides and small molecules derived from DGX-001, targeting cognitive impairment, depression, anxiety, and inflammatory diseases.

Research & Development

Viage Therapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Viage Therapeutics	5	obfuscated obfuscation	Remiges Ventures	Seed
obfuscated obfuscation	Seed Round - Viage Therapeutics	5	obfuscated obfuscation	Remiges Ventures	Seed
obfuscated obfuscation	Seed Round - Viage Therapeutics	5	obfuscated obfuscation	Remiges Ventures	Seed
obfuscated obfuscation	Seed Round - Viage Therapeutics	5	obfuscated obfuscation	Remiges Ventures	Seed
obfuscated obfuscation	Seed Round - Viage Therapeutics	5	obfuscated obfuscation	Remiges Ventures	Seed

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Seed Round - Viage Therapeutics	5	obfuscated obfuscation	Remiges Ventures	Seed
obfuscated obfuscation	Seed Round - Viage Therapeutics	5	obfuscated obfuscation	Remiges Ventures	Seed
obfuscated obfuscation	Seed Round - Viage Therapeutics	5	obfuscated obfuscation	Remiges Ventures	Seed
obfuscated obfuscation	Seed Round - Viage Therapeutics	5	obfuscated obfuscation	Remiges Ventures	Seed
obfuscated obfuscation	Seed Round - Viage Therapeutics	5	obfuscated obfuscation	Remiges Ventures	Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Kyoto University Innovation Capital	—	Seed Round - Viage Therapeutics	—
Kyoto University Innovation Capital	—	Seed Round - Viage Therapeutics	—
Kyoto University Innovation Capital	—	Seed Round - Viage Therapeutics	—
Kyoto University Innovation Capital	—	Seed Round - Viage Therapeutics	—
Kyoto University Innovation Capital	—	Seed Round - Viage Therapeutics	—